Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Diabetes type 2 - insulin secretagogues in all type of patients - insulin secretagogues - DPP-4 inhibitors in all types of patients - antidiabetic drugs in patients inadequately controlled on metformin - antidiabetic drugs in patients inadequately controlled on monotherapy - antidiabetic drugs in patients with insufficient glycaemic control with bitherapy - glucose lowering for cardiovascular prevention in all type of patients |
Stafford , 2011 | sitagliptin | | | NA | | | NCT00451113 |
Reasner, 2011 | sitagliptin | control (add on MET) | | NA | | | NCT00482729) |
Arechavaleta, 2011 | sitagliptin | glimepiride (add on MET) | | 1035 (516/519) | | | NCT00701090 |
Goldstein (sit vs met), 2007 | sitagliptin | metformin | | NA | | | |
Goldstein (sit+met vs met), 2007 | sitagliptin | metformin | | NA | | | |
Pérez-Monteverde, 2011 | sitagliptin | pioglitazone | | NA | | | NCT00541450 |
Goldstein, 2007 | sitagliptin | placebo | | NA | | | NCT00103857 |
Hanefeld, 2007 | sitagliptin | placebo | | NA | | | |
TECOS, 2015 | sitagliptin | placebo | | 14671 (7332/7339) | Exploratory | | NCT00790205 |
Vilsbøll, 2010 | sitagliptin | placebo (add on insulin+/-MET) | | 641 (322/319) | | | NCT00395343 |
Charbonnel, 2006 | sitagliptin | placebo (add on MET) | | NA | | | NCT0086515 |
Nauck, 2007 | sitagliptin | placebo (add on MET) | | NA | | | NCT00094770 |
raz, 2008 | sitagliptin | placebo (add on MET) | | NA | | | NCT00337610 |
Scott** (sit vs pbo on top met), 2007 | sitagliptin | placebo (add on MET) | | NA | | | |
Rosenstock , 2006 | sitagliptin | placebo (add on PIO) | | NA | | | NCT00086502 |
Rosenstock (sit on top pio vs pbo), 2006 | sitagliptin | placebo (on top PIO) | | NA | | | NCT00086502 |
Hermansen, 2007 | sitagliptin | placebo (on-top glimepiride+/- metformine) | | NA | | | |
Rigby , 2010 | sitagliptin | rosiglitazone (add on MET) | | NA | | | |
Al Sifri, 2011 | sitagliptin | Sulphonylurea (on top MET) | | 1021 (507/514) | | | |
Scott* (sit vs glipi), 2007 | sitagliptin 50mg bid monotherapy | glipizide | | NA | | | |
Scott* (sit vs pbo), 2007 | sitagliptin 50mg bid monotherapy | placebo | | NA | | | |
Aschner, 2010 | sitagliptin monotherapy | metformin | | 1050 (528/522) | | | NCT00449930 |
Aschner, 2006 | sitagliptin monotherapy | placebo | | NA | | | NCT00087516 |
Barzilai, 2011 | sitagliptin monotherapy | placebo | | NA | | | NCT00305604 |
Chan, 2008 | sitagliptin monotherapy | placebo | | 91 (65/26) | | | |
Mohan , 2009 | sitagliptin monotherapy | placebo | | NA | | | |
Nonaka, 2008 | sitagliptin monotherapy | placebo | | NA | | | NCT00371007 |
Raz, 2006 | sitagliptin monotherapy | placebo | | NA | | | |
Iwamoto , 2010 | sitagliptin monotherapy | voglibose | | NA | | | |
Derosa , 2010 | sitagliptin+pio | metformin+pio | | NA | | | |